CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-05 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −4,963 | $98.50 | $489K | 60,000 |
| 2021-10-05 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −4,963 | 95,037 | ||
| 2021-08-17 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Option exercise | +30,000 | $2.23 | $67K | 60,000 |
| 2021-08-17 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Option exercise · Stock Option (right to buy) | −30,000 | 133,294 | ||
| 2021-08-16 | McLoughlin Margaret Director | Option exercise | +6,000 | $17.00 | $102K | 6,000 |
| 2021-08-16 | McLoughlin Margaret Director | Sale | −3,056 | $94.55 | $289K | 2,944 |
| 2021-08-16 | McLoughlin Margaret Director | Sale | −1,044 | $95.57 | $100K | 1,900 |
| 2021-08-16 | McLoughlin Margaret Director | Sale | −1,429 | $96.51 | $138K | 471 |
| 2021-08-16 | McLoughlin Margaret Director | Sale | −423 | $97.55 | $41K | 48 |
| 2021-08-16 | McLoughlin Margaret Director | Sale | −48 | $98.90 | $5K | 0 |
| 2021-08-16 | McLoughlin Margaret Director | Option exercise · Stock Option (right to buy) | −6,000 | 85,911 | ||
| 2021-08-16 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Option exercise | +22,000 | $2.23 | $49K | 52,000 |
| 2021-08-16 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −9,158 | $94.23 | $863K | 42,842 |
| 2021-08-16 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −7,335 | $95.02 | $697K | 35,507 |
| 2021-08-16 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −2,330 | $96.32 | $224K | 33,177 |
| 2021-08-16 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −1,100 | $97.28 | $107K | 32,077 |
| 2021-08-16 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −2,077 | $98.90 | $205K | 30,000 |
| 2021-08-16 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Option exercise · Stock Option (right to buy) | −22,000 | 163,294 | ||
| 2021-08-10 | Detke Michael J. Chief Medical Officer | Option exercise | +10,000 | $2.23 | $22K | 10,000 |
| 2021-08-10 | Detke Michael J. Chief Medical Officer | Sale | −10,000 | $100.00 | $1.0M | 0 |
Page 9 of 18 · 350 trades